BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-15
DOI
10.1038/s41416-018-0217-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BRCA1 gene: function and deficiency
- (2017) Miho Takaoka et al. International Journal of Clinical Oncology
- PARP inhibitors in ovarian cancer
- (2016) J. A. Ledermann ANNALS OF ONCOLOGY
- Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers
- (2016) Sara Notaro et al. BMC CANCER
- Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis
- (2016) Renaud Sabatier et al. Familial Cancer
- Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status
- (2016) Joanne Kotsopoulos et al. GYNECOLOGIC ONCOLOGY
- BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study
- (2016) Philipp Harter et al. GYNECOLOGIC ONCOLOGY
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients – A study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD)
- (2014) I. Ruscito et al. EUROPEAN JOURNAL OF CANCER
- BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study
- (2013) J L Lesnock et al. BRITISH JOURNAL OF CANCER
- Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients
- (2011) G Goebel et al. BRITISH JOURNAL OF CANCER
- BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer
- (2011) Judith E. Carser et al. GYNECOLOGIC ONCOLOGY
- Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
- (2011) Da Yang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
- (2008) Joshua Z Press et al. BMC CANCER
- Secondary BRCA1 Mutations in BRCA1-Mutated Ovarian Carcinomas with Platinum Resistance
- (2008) E. M. Swisher et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started